PGs (prostaglandins) are synthesized through the cyclo-oxygenase (COX-1 and -2) pathway in a variety of cells in response to various physiological stimuli. All cells require at least one pathway for apoptosis, and mitochondrial play a central role in regulation of apoptosis. In a previous study, incubation of A549 cells with NS-398 (a COX-2-specific inhibitor) induced apoptosis and inhibited cell proliferation, and the concentrations of different PGs between various cellular compartments were found to be changed. To determine whether PG receptors are involved in this regulation, Western-blot analyses were performed specific for PGE 2 (EP receptors) and PGF 2α (FP receptor) receptors, which were expressed in A549 cells. Western-blot analysis revealed that mitochondria that were isolated from A549 cells expressed EP receptors (EP2, EP3 and EP4), whereas FP receptors were undetectable. EP receptors (EP1, EP3 and EP4) and FP receptors were detected from A549 cell membrane. These results suggest that the change of PG production in A549-cells-induced cancer cell apoptosis might be related to the different expressions of EP and FP receptors in cell and mitochondrial membrane.
Introduction
Apoptosis is a distinct morphological and biochemical cell death event, allowing a multicellular organism efficiently to remove old, superfluous or damaged cells in a process that is distinct from necrosis [1] , and mitochondria play a central role in regulation of apoptosis [2] . A variety of key events in apoptosis focus on mitochondria, including the release of caspase activators (such as cytochrome c), change in electron transport and loss of mitochondrial transmembrane potential. In mammalian cells, a major caspase activation pathway is the cytochrome c-mediated pathway. In this pathway, a variety of apoptotic stimuli cause cytochrome c release from mitochondria, which in turn induces a series of biochemical reactions that result in caspase activation and subsequent cell death [3] . Prostanoids are a group of lipid mediators that includes PG (prostaglandin) and thromboxane. In response to cell stimulation, prostanoids are synthesized by the COX (cyclo-oxygenase) pathway from arachidonic acid released from membrane phospholipids by the action of phospholipases [4] . COX, a key enzyme in the conversion of arachidonic acid into PGs and other eicosanoids, exists as two isoforms: COX-1 and COX-2 [5] . COX-1 is constitutively expressed, whereas COX-2 is a highly inducible gene that is activated by cytokines, growth factors and other chemical carcinogens, and has a putative role in carcinogenesis and inflammation [6, 7] . NS-398, a kind of non-steroidal antiinflammatory drugs (NSAIDs), is an effective and selective COX-2 inhibitor [8] , and has been found to induce apoptosis Key words: apoptosis, cyclo-oxygenase, cytochrome c, mitochondrion, prostaglandin receptor.
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in various cancer cells [9] . Several hypotheses have been proposed to explain how increased COX-2 expression might contribute to carcinogenesis [10, 11] . Apart from these results, very little is understood about the functions of PGs and the expression of PG receptors in plasma and mitochondrial membrane in apoptosis induced by NS-398. In the present study, A549 cells, a type of human lung carcinoma cell line, were used to study the effects of NS-398 on apoptosis and expression of PG receptors in plasma and mitochondrial membrane.
Induction of apoptosis by NS-398
To determine the effect of NS-398, the A549 cell line was grown in monolayer and treated with 0, 10, 25, 50, 75 and 100 µM of NS-398 for 48 h in Dulbecco's modified Eagle's medium (Biochrom, Berlin, Germany). Cell viability performed by MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide] assay showed that cells were significantly decreased in A549 cells treated with NS-398, and the results were all <50% when concentrations of NS-398 were >50 µM ( Figure 1A) . A DNA fragmentation assay confirmed that A549 cells underwent apoptosis after treatment with various concentrations of NS-398 ( Figure 1B ), and incubation with 50 µM NS-398 resulted in decreased cell viability.
Cytochrome c released from mitochondria
To examine whether NS-398 triggers cytochrome c release from mitochondria, cytochrome c in mitochondrial fractions, obtained by Mitochondria Isolation kit (Sigma, St. Louis, MO, U.S.A.), released in A549 cells was assayed after treatment with various concentrations of NS-398 for 48 h. Results showed that release of cytochrome c was induced by NS-398, and at the concentration of 25 µM, the release of cytochrome c was at a maximum ( Figure 1C ). The release of cytochrome c was gradually reduced after treatment with 50-100 µM NS-398. This result suggests that NS-398 is not the only factor involved in the up-regulation in apoptosis related to the release of cytochrome c in the A549 cell line.
Expression of EP and FP receptors
Although NS-398 induced apoptosis and up-regulated cytochrome c release in A549 cells, expression of EP (EP1, EP2, EP3 and EP4 for PGE 2 ) and FP (for PGF 2α ) receptors was found to be facilitated by treatment with NS-398. Ex- pressions of EP and FP receptors were analysed by immunoblotting. It is interesting to find that not only does the plasma membrane express EP and FP receptors, but the mitochondrial membrane also expresses different EP receptors. This is the first report to show the expression of PG receptors in mitochondrial membrane. Immunoblotting analysis revealed that EP1, EP3, EP4 and FP receptors were expressed significantly after treatment with NS-398 (Figures 2A-2D ) in plasma membrane, and EP2 receptor was not detectable. In mitochondrial membrane, only EP2, EP3 and EP4 receptors were expressed ( Figures 2E-2G ), but not EP1 and FP receptors. No FP receptor found in mitochondrial fractions showed that there was any contamination by plasma membrane that was found to express FP receptor. It is known that PGs, particular PGE 2 and PGF 2α are important physiological mediators in maintaining normal functions in cells. Effects of various PGs are also dependent on the amount of PG receptors expressed in membrane. According to our results, NS-398, a selective COX-2 inhibitor, affects not only the synthesis of various PGs through COX-2, but also seems to regulate the expression of EP and FP receptors in plasma and mitochondrial membrane to achieve the maximum effects of PGs. In a previous study, we found that after treatment of A549 cells with NS-398, PGF 2α uptake was significant from cytosol to mitochondrial matrix [12] . All these results suggest that PGs, particularly of PGF 2α , play a putative role in the regulation of cell apoptosis, and are probably involved in the release of cytochrome c from mitochondrial membrane. Moreover, different expression of EP and FP receptors in plasma and mitochondrial membrane offers a degree of selectivity in the modulation of apoptosis by PGs.
